CompletedNCT03019887
Official study titleCorrelation Between Cognitive Function and Relapse of Schizophrenia Regarding Dose Reduction in Patients Undergoing High-dose Antipsychotic Therapy
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 20–70
- Countries
- Sponsor
- Juntendo University
CompletedNCT00140192
Official study titleCreatine as a New Treatment for Schizophrenia:A Double-Blind Trial
This study has finished and is no longer accepting participants.
In BeershevaSchizophreniaMedication studyAges 18–60
- Countries
- Israel
- Sponsor
- Beersheva Mental Health Center
CompletedNCT03317769
Official study titleCreating Live Interactions to Mitigate Barriers (CLIMB): A Mobile Intervention to Improve Social Functioning in People With Schizophrenia
This study has finished and is no longer accepting participants.
In San FranciscoSchizophreniaInterventional studyAges 18–60
- Countries
- United States
- Sponsor
- Posit Science Corporation
CompletedNCT00356317
Official study titleA Culturally Based Family Therapy for Schizophrenia
This study has finished and is no longer accepting participants.
In Coral GablesSchizophreniaBehavioural studyAges 13+
- Countries
- United States
- Sponsor
- University of Miami
CompletedNCT02298985
Official study titleCurcumin as add-on to Antipsychotic Treatment in Chronic Schizophrenia Patients: A Randomized, Double-Blind, Placebo-controlled Study
This study has finished and is no longer accepting participants.
Multiple locations, including BeershevaSchizophreniaMedication studyAges 18–60
- Countries
- Israel
- Sponsor
- Beersheva Mental Health Center
CompletedNCT03669250
Official study titleA Placebo-Controlled Study to Evaluate the Effect of a Single Dose of CVN058 on Mismatch Negativity in Subjects With Stable Schizophrenia
This study has finished and is no longer accepting participants.
In New YorkSchizophreniaMedication studyAges 18–50
- Countries
- United States
- Sponsor
- Cerevance Alpha, Inc.
CompletedNCT00960219
What is this study about?This study assessed thinking abilities.
This study has finished and is no longer accepting participants.
In TaichungSchizophreniaMedication studyAges 18–65
- Countries
- Taiwan
- Sponsor
- China Medical University Hospital
CompletedNCT00963924
Official study titleA Placebo-controlled Trial of D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia
This study has finished and is no longer accepting participants.
In BostonSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT02156908
Official study titleD-serine and Cognitive Remediation in Schizophrenia: Open Label Pilot
This study has finished and is no longer accepting participants.
In OrangeburgSchizophreniaMedication studyAges 18–64
- Countries
- United States
- Sponsor
- Nathan Kline Institute for Psychiatric Research
SuspendedNCT05046353
Official study titleD-serine Augmentation of Neuroplasticity-based Auditory Learning in Schizophrenia: R33 Phase
Recruitment is currently suspended.
In New YorkSchizophreniaMedication studyAges 18–50
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
CompletedNCT03711500
Official study titleD-serine Augmentation of Neuroplasticity Based Auditory Learning in Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including New YorkSchizophreniaMedication studyAges 18–50
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
CompletedNCT00826202
Official study titleD-Serine vs Placebo for the Schizophrenia Prodrome
This study has finished and is no longer accepting participants.
Multiple locations, including New HavenSchizophreniaMedication studyAges 13–35
- Countries
- United States
- Sponsor
- Nathan Kline Institute for Psychiatric Research